Neuropsychologic functioning and health status in systemic lupus erythematosus: Does ethnicity matter?

Journal of Clinical Rheumatology

Volumn 11, Issue 5, 2005, Pages 250-256

  Doninger, Nicholas A ^a,c   Fink, Joseph W ^b   Utset, Tammy O ^b  

^a Kettering Medical Center Network   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c Wallace Kettering Neuroscience Institute   (United States)

Author keywords

Ethnicity; Health; Lupus; Neuropsychologic functioning

Indexed keywords

ADULT; ANXIETY; ARTICLE; ATTENTION; COGNITION; COPING BEHAVIOR; DEPRESSION; DISEASE SEVERITY; EMPLOYMENT; ETHNOLOGY; FATIGUE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOTOR ACTIVITY; NEGRO; NEPHRITIS; NEUROPSYCHIATRY; NEUROPSYCHOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE; SYSTEMIC LUPUS ERYTHEMATOSUS; VERBAL MEMORY; VISUAL MEMORY; WELLBEING; WORKING MEMORY;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; CHICAGO; COGNITION DISORDERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; NEPHRITIS; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 26944455135     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000182149.67967.cc     Document Type: Article

References (73)

1. Cook RJ, Gladman DD, Pericak D, et al. Prediction of short mortality in systemic lupus erythematosus with time dependent measures of disease activity. J Rheumatol. 2000;27:1892-1895.
2. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599-608; Appendix C.
3. McCune WJ, Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am. 1988;14:149-167.
4. Hanly JG, Liang MH. Cognitive disorders in systemic lupus erythematosus: epidemiologic and clinical issues. Ann N Y Acad Sci. 1997;823: 60-68.
5. Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57: 496-500.
6. Carbotte R, Denburg S, Denburg J. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis. 1986;174:357-364.
7. Denburg S, Carbotte R, Denburg J. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol. 1987;9:323-339.
8. Kutner K, Busch H, Mahmood T, et al. Neuropsychological functioning in systemic lupus erythematosus. Neuropsychology. 1988;2:119-126.
9. Denburg SD, Carbotte RM, Denburg JA. Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatol. 1997;24:998-1003.
10. Kozora E, West S, Kotzin B, et al. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1998;41:41-47.
11. Denburg SD, Carbotte RM, Ginsberg JS, et al. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc. 1997;3:377-386.
12. Glanz B, Slonim D, Urowitz M, et al. Pattern of neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neural. 1997;10:232-238.
13. Kozora E, Thompson L, West S, et al. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1996;39:2035-2045.
14. Loukkola J, Laine M, Ainiala H, et al. Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study. J Clin Exp Neuropsychol. 2003;25:145-151.
15. Menon A, Jameson-Shortall E, Newman S, et al. A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum. 1999;42:735-741.
16. Skeel R, Johnstone B, Yangco D, et al. Neuropsychological deficit profiles in systemic lupus erythematosus. Appl Neuropsychol. 2000;7: 96-101.
17. Carbotte RM, Denburg SD, Denburg JA. Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives. Arthritis Rheum. 1995;38:1363-1374.
18. Jordan JM, Lawrence R, Kington R, et al. Ethnic health disparities in arthritis and musculoskeletal diseases: report of a scientific conference. Arthritis Rheum. 2002;46:2280-2286.
19. Breitbach SA, Alexander RW, Daltroy LH, et al. Determinants of cognitive performance in systemic lupus erythematosus. J Clin Exp Neuropsychol. 1998;20:157-166.
20. Centers for Disease Control and Prevention. Trends in deaths from systemic lupus erythematosus-United States, 1979-1998. MMWR Surveill Summ. 2002;51:371-374.
21. Hochberg MC. Epidemiology of SLE. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus, 4th ed. Philadelphia: Lea & Febiger; 1992.
22. McCarty DJ, Manzi S, Medsger TA, et al. Incidence of systemic lupus erythematosus. Race and gender differences. Arthritis Rheum. 1995;38: 1260-1270.
23. Walsh SJ, Algert C, Gregorio DI, et al. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol. 1995;22:1663-1668.
24. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcome. Arthritis Rheum. 1995;38:274-283.
25. Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. Lupus in Minority populations: Nature vs nurture. Lupus. 1999;8:197-209.
26. Ginzler EM, Diamond HS, Weiner M, et al. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25:601-611.
27. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991;91:345-353.
28. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:47-56.
29. Reveille JD, Moulds JM, Ahn C, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998;41:1161-1172.
30. Uribe AG, McGwin G, Reveille JD, et al. What we have learned from a 10-year experience with the lumina (lupus in minorities; nature vs nurture) cohort? Where are we heading? Autoimmun Rev. 2004;3: 321-329.
31. Devins GM, Edworthy SM. Illness intrusiveness explains race-related quality-of-life differences among women with systemic lupus erythematosus. Lupus. 2000;9:534-541.
32. Petri M. The effect of race on incidence and clinical course in systemic lupus erythematosus: the Hopkins Lupus Cohort. J Am Med Womens Assoc. 1998;53:9-12.
33. Hanly JG, Fisk JD, Sherwood G, et al. Clinical course of cognitive dysfunction in systemic lupus erythematosus. J Rheumatol. 1994;21: 1825-1831.
34. Arbuckle MR, James JA, Dennis GJ, et al. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 2003;12:99-106.
35. McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. 2004;50:1226-1232.
36. Segasothy M, Phillips PA. Systemic lupus erythematosus in Aborigines and Caucasians in central Australia: a comparative study. Lupus. 2001; 10:439-444.
37. Leritz E, Brandt J, Minor M, et al. Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. J Clin Exp Neuropsychol. 2002;24:527-533.
38. Hanly J, Hong C, Smith S, et al. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum. 1999;42:728-734.
39. Afeltra A, Garzia P, Mitterhofer AP, et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology. 2003;61:108-110.
40. Alarcon GS, Cianfrini L, Bradley LA, et al. Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory. Arthritis Rheum. 2002;47:310-319.
41. Holliday SL, Navarrete MG, Hermosillo-Romo D, et al. Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus. 2003;12:697-703.
42. Hochberg MC. Updating the American College of Rheumatology revised criterion for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
43. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International-Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363-369.
44. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:809-813.
45. Lezak MD. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press; 1995.
46. Nelson HE. The National Adult Reading Test (NART): Test Manual. Windsor, Berks, UK: NFER-Nelson; 1982.
47. Delis DC, Kramer JH, Kaplan E, et al. California Verbal Learning Test: Adult Version. San Antonio: Psychological Corp; 1987.
48. Meyers J, Meyers K. The Meyers Scoring System for the Rey Complex Figure and Recognition Trial: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1995.
49. Golden CJ. Stroop Color and Word Test. Chicago: Stoelting; 1978.
50. Smith A. Symbol Digit Modalities Test. Los Angeles: Western Psychological Services; 1991.
51. Wechsler D. Wechsler Adult Intelligence Scale-Third Edition: Administration and Scoring Manual. New York: Psychological Corp; 1997.
52. Heaton RK, Grant I, Anthony WZ, et al. A comparison of clinical and automated interpretation of the Hallstead-Reitan battery. J Clin Neuropsychol. 1981;3:121-141.
53. Heaton RK, Grant I, Butters N, et al. The HNRC 500-neuropsychology of HIV infection at different stages. J Int Neuropsychol Soc. 1995;1: 231-251.
54. Heaton RK, Grant I, Matthews CG. Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, FL: Psychological Assessment Resources; 1991.
55. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30: 191-197.
56. Dudgeon D, Raubertas RF, Rosenthal SN. The short-form McGill Pain Questionnaire in chronic cancer pain. J Pain Symptom Manage. 1993;8: 191-195.
57. Spielberger CD. Manual for the Spielberger Sate Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
58. Smets EM, Garssen B, Bonke B, et al. The multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315-325.
59. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I: Conceptual framework and item selection. Med Care. 1992; 30:473-483.
60. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short-form health survey (SF-36). II: Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31: 247-263.
61. Stoll T, Gordon C, Seifert B, et al. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol. 1997;24:1608-1614.
62. Strand V, Gladman D, Isenberg D, et al. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol. 1999; 26:490-497.
63. Fortin PR, Abrahamowicz M, Neville C, et al. Impact of disease activity and cumulative damage on the health of lupus patients. Lupus. 1998;7:101-107.
64. Wang C, Mayo NE, Fortin PR. The relationship between health related quality of life and disease activity and damage in systemic lupus erythematosus. J Rheumatol. 2001;28:525-532.
65. Dobkin PL, DaCosta D, Dritsa M, et al. Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. Arthritis Care Res. 1999;12:401-410.
66. Gordon C, Exley AR, Clay C. Changes in SF-36 scores in SLE with change in disease activity measured by the BILAG index. Arthritis Rheum. 1997;40:S112.
67. Geisser S, Greenhouse SW. An extension of Box's results on the use of the F distribution in multivariate analysis. Ann Math Stat. 1958;29: 885-891.
68. Levene H. Robust tests for equality of variances. In: Olkin I, ed. Contributions to Probability and Statistics: Essays in Honor of Harold Hotelling. Stanford, CA: Stanford University Press; 1960:278-292.
69. Sweet JJ, Doninger NA, Zee PC, et al. Factors influencing cognitive function, sleep, and quality of life in individuals with systemic lupus erythematosus: a review of the literature. Clin Neuropsychol. 2004;18: 132-147.
70. Doninger NA, Utset TO, Lacy M. Associations of cognitive function in systemic lupus erythematosus. Clin Neuropsychol. 2003;17:91.
71. Mulherin E, Doherty E, O'Connell A, et al. Assessment of cognitive function in patients with systemic lupus erythematosus. Ir J Med Sci. 1993;162:9-12.
72. McLaurin EY, Holliday SL, Williams P, et al. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology. 2005;64:297-303.
73. Payers PM, Hand DJ, Bjordal K, et al. Causal indicators in quality of life research. Qual Life Res. 1997;6:393-406.